Free Trial

Veeva Systems Inc. $VEEV Holdings Lowered by Ninety One UK Ltd

Veeva Systems logo with Medical background

Key Points

  • Ninety One UK Ltd reduced its stake in Veeva Systems Inc. by 10.3% during the second quarter, now holding approximately 0.06% of the company valued at $28.4 million.
  • Several hedge funds, including Nuveen LLC and Price T Rowe Associates, have increased their holdings in Veeva Systems, with overall institutional ownership at 88.20%.
  • Veeva Systems has seen analyst upgrades, with Canaccord Genuity raising their price target from $270 to $300, and a consensus rating of "Moderate Buy" with an average price target of $303.67.
  • Interested in Veeva Systems? Here are five stocks we like better.

Ninety One UK Ltd trimmed its stake in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 10.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 98,701 shares of the technology company's stock after selling 11,391 shares during the period. Ninety One UK Ltd owned about 0.06% of Veeva Systems worth $28,424,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of VEEV. Nuveen LLC purchased a new stake in shares of Veeva Systems during the first quarter valued at $365,684,000. Price T Rowe Associates Inc. MD lifted its stake in Veeva Systems by 20.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,992,372 shares of the technology company's stock worth $924,754,000 after acquiring an additional 689,700 shares in the last quarter. Linonia Partnership LP lifted its stake in Veeva Systems by 52.7% in the 1st quarter. Linonia Partnership LP now owns 1,836,557 shares of the technology company's stock worth $425,402,000 after acquiring an additional 633,585 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Veeva Systems by 48.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,799,931 shares of the technology company's stock worth $416,918,000 after acquiring an additional 585,785 shares in the last quarter. Finally, Alliancebernstein L.P. lifted its stake in Veeva Systems by 10.7% in the 1st quarter. Alliancebernstein L.P. now owns 5,499,651 shares of the technology company's stock worth $1,273,884,000 after acquiring an additional 532,269 shares in the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.

Veeva Systems Trading Up 1.7%

Shares of VEEV stock opened at $298.00 on Wednesday. The stock has a 50 day moving average of $281.23 and a two-hundred day moving average of $261.68. The company has a market capitalization of $48.85 billion, a P/E ratio of 61.19, a P/E/G ratio of 2.26 and a beta of 0.95. Veeva Systems Inc. has a 12 month low of $200.30 and a 12 month high of $299.95.

Insider Buying and Selling at Veeva Systems

In other Veeva Systems news, SVP Jonathan Faddis sold 720 shares of Veeva Systems stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $285.62, for a total value of $205,646.40. Following the completion of the transaction, the senior vice president owned 7,902 shares in the company, valued at approximately $2,256,969.24. The trade was a 8.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Priscilla Hung sold 172 shares of the business's stock in a transaction on Thursday, July 3rd. The stock was sold at an average price of $283.00, for a total value of $48,676.00. Following the sale, the director owned 4,137 shares of the company's stock, valued at approximately $1,170,771. The trade was a 3.99% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,063 shares of company stock valued at $302,955. Corporate insiders own 10.30% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on VEEV. Canaccord Genuity Group increased their price objective on Veeva Systems from $270.00 to $300.00 and gave the stock a "hold" rating in a research note on Thursday, August 28th. Wells Fargo & Company increased their price objective on Veeva Systems from $300.00 to $326.00 and gave the stock an "overweight" rating in a research note on Tuesday, August 26th. Stifel Nicolaus increased their price objective on Veeva Systems from $295.00 to $320.00 and gave the stock a "buy" rating in a research note on Thursday, August 28th. Piper Sandler increased their price objective on Veeva Systems from $325.00 to $355.00 and gave the stock an "overweight" rating in a research note on Thursday, August 28th. Finally, Needham & Company LLC raised their price target on Veeva Systems from $300.00 to $355.00 and gave the stock a "buy" rating in a research note on Thursday, August 28th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $303.67.

Read Our Latest Stock Analysis on VEEV

About Veeva Systems

(Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Read More

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.